Navot D, Anderson T L, Droesch K, Scott R T, Kreiner D, Rosenwaks Z
Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk 23507.
J Clin Endocrinol Metab. 1989 Apr;68(4):801-7. doi: 10.1210/jcem-68-4-801.
Three experimental protocols were devised to induce endometrial maturation in 12 women with ovarian failure. Each was planned to serve a dual purpose: to resolve a particular clinical situation related to synchronization between ovum donor and recipient and to answer a specific question about endometrial physiology. A fourth protocol of sequential estrace (2-6 mg/day) and progesterone (P4; 25-50 mg/day, im) simulating the 28-day natural cycle, served as a control protocol (18 cycles). A short follicular phase protocol consisted of only 6 days of estrogen (E) administration before addition of P4 (13 cycles). In the long follicular phase protocol (5 cycles), estrace was given for 3-5 weeks, and P4 administration was accordingly postponed. In 6 accelerated secretory transformation cycles, 150 mg/day P4 were administered, im, from day 15 onward. The adequacy of the induced endometrial cycles was evaluated by hormonal, morphological, and histochemical criteria relevant to endometrial normalcy and receptivity. Serum estradiol levels and the areas under the estradiol curves for the long and short follicular phase protocols differed significantly from those during the control cycles (P less than 0.005). Areas under the estradiol curves in the accelerated secretory transformation protocol yielded significantly higher P4 values than those in all other protocols (P less than 0.05). All biopsies in the 3 experimental protocols compared favorably with those of the control protocol. Glycocalyx intensity (periodic acid-Schiff) and the amount of galactose residues in the glycocalyx (Ricinus communis-I agglutinin) were greatest during the periimplantation interval. We conclude that a very short exposure of the human endometrium to E or, conversely, prolonged E stimulation will allow normal endometrial maturation with the addition of P4. Supraphysiological doses of P4 in the accelerated secretory transformation protocol significantly enhanced endometrial maturational processes.
设计了三种实验方案来诱导12名卵巢功能衰竭女性的子宫内膜成熟。每个方案都旨在实现双重目的:解决与卵子供体和受体同步相关的特定临床情况,并回答一个关于子宫内膜生理学的特定问题。第四个方案是连续使用雌二醇(2 - 6毫克/天)和孕酮(P4;25 - 50毫克/天,肌肉注射)模拟28天自然周期,作为对照方案(18个周期)。短卵泡期方案包括在添加P4之前仅给予6天雌激素(E)(13个周期)。在长卵泡期方案(5个周期)中,给予雌二醇3 - 5周,并相应推迟P4给药。在6个加速分泌转化周期中,从第15天起每天肌肉注射150毫克P4。通过与子宫内膜正常和接受性相关的激素、形态学和组织化学标准评估诱导的子宫内膜周期的充分性。长卵泡期和短卵泡期方案的血清雌二醇水平以及雌二醇曲线下面积与对照周期相比有显著差异(P小于0.005)。加速分泌转化方案中雌二醇曲线下面积产生的P4值明显高于所有其他方案(P小于0.05)。3个实验方案中的所有活检结果与对照方案相比都更好。糖萼强度(过碘酸 - 希夫反应)和糖萼中半乳糖残基的量(蓖麻凝集素 - I)在着床期最大。我们得出结论,人类子宫内膜对E的极短暴露或相反地,延长E刺激并添加P4将允许正常的子宫内膜成熟。加速分泌转化方案中超生理剂量的P4显著增强了子宫内膜成熟过程。